FrancophonIA/ELRC3.0 huggingface dataset:
English: ZYPREXA Injection is for intramuscular use.
Slovenian: ZYPREXA injekcija je za intramuskularno uporabo.
English: The maximum daily dose of olanzapine (including all formulations of olanzapine) is 20 mg.
Slovenian: Najvišji dnevni odmerek olanzapina (velja za vse oblike olanzapina) je 20 mg.
English: It is important that you carry on taking ZYPREXA for as long as your doctor tells you.
Slovenian: Pomembno je, da nadaljujete z jemanjem zdravila ZYPREXA tako dolgo, kot vam naroči zdravnik.
English: A combination of ZYPREXA with the following medicines might make you feel drowsy: medicines taken for anxiety or to help you sleep (tranquillisers, including benzodiazepines), and antidepressants.
Slovenian: Kombinacija zdravila ZYPREXA z naslednjimi zdravili lahko povzroči, da se počutite zaspani: zdravila za zdravljenje občutkov tesnobe ali ki vam pomagajo spati (pomirjevala, vključno z benzodiazepini) in zdravila za zdravljenje depresije.
English: The recommended initial dose for olanzapine injection is 10 mg, administered as a single intramuscular injection.
Slovenian: Priporočeni začetni odmerek za injekcijo olanzapina je 10 mg, injiciran kot posamezna intramuskularna injekcija.
English: 13Undesirable effects listed and observed following administration of oral and LAIM olanzapine, which may also occur following administration of RAIM olanzapine.
Slovenian: 13 Neželeni učinki, navedeni in opazovani po uporabi peroralnega in LAIM olanzapina, se lahko pojavijo tudi po uporabi zdravila RAIM olanzapin.
English: Potential for interaction following intramuscular injection In a single dose intramuscular study of olanzapine 5 mg, administered 1 hour before intramuscular lorazepam 2 mg (metabolised by glucuronidation), the pharmacokinetics of both medicines were unchanged.
Slovenian: Možnost za medsebojno delovanje po intramuskularnem injiciranju V študiji enkratnega odmerka 5 mg intramuskularnega olanzapina, danega 1 uro pred 2 mg intramuskularnim odmerkom lorazepama (ki se presnavlja z glukuronidacijo), sta bili farmakokinetiki obeh zdravil nespremenjeni.
English: Information on reconstitution and administration is provided in a detachable section at the end of this leaflet.
Slovenian: Podatki o pripravi in dajanju so v odstavku na koncu tega lističa, ki ga je mogoče odtrgati.
English: In clinical trials with ZYPREXA powder for solution for injection, olanzapine was not associated with a persistent increase in absolute QT or in QTc intervals.
Slovenian: V kliničnih preskušanjih ZYPREXA praška za raztopino za injiciranje olanzapina niso povezovali z vztrajajočim podaljšanjem absolutnih QT ali QTc intervalov.
English: Patients should remain recumbent if dizzy or drowsy after injection until examination indicates that they are not experiencing hypotension including postural hypotension, bradyarrhythmia and/or hypoventilation.
Slovenian: Če so bolniki po injekciji omotični ali zaspani, naj ostanejo v ležečem položaju, dokler pregled ne pokaže, da nimajo hipotenzije, vključno s posturalno hipotenzijo, bradiaritmijo in/ali hipoventilacijo.
English: 28 coated tablets 35 coated tablets 56 coated tablets 70 coated tablets 98 coated tablets
Slovenian: 28 obloženih tablet 35 obloženih tablet 56 obloženih tablet 70 obloženih tablet 98 obloženih tablet
English: The mean increase in olanzapine Cmax following fluvoxamine was 54 % in female nonsmokers and 77 % in male smokers.
Slovenian: Srednje zvišanje Cmax olanzapina po dajanju fluvoksamina je bilo 54 % pri ženskah nekadilkah in 77
English: • Mania, a condition with symptoms of excitement or euphoria.
Slovenian: • maniji, bolezni s simptomi razburjenja ali evforije.
English: The daily dose of ZYPREXA is between 5 mg and 20 mg.
Slovenian: Dnevni odmerek zdravila ZYPREXA je med 5 mg in 20 mg.
English: You should not be given this medicine when breast-feeding, as small amounts of ZYPREXA can pass into breast milk.
Slovenian: Ko dojite, tega zdravila ne smete jemati, ker lahko majhne količine zdravila ZYPREXA prehajajo v materino mleko.
English: Very common adverse reactions associated with the use of olanzapine in this patient group were abnormal gait and falls.
Slovenian: Zelo pogosti neželeni reakciji povezani z uporabo olanzapina v tej skupini bolnikov sta bili neobičajna hoja in padci.
English: The pharmacokinetic variability observed in the elderly is within the range for the nonelderly.
Slovenian: Farmakokinetična variabilnost, opažena pri starejših, je v okvirih razpona za nestarejše.
English: • In addition the different ZYPREXA tablet strengths also contain the following ingredients:
Slovenian: - Dodatno vsebujejo različne jakosti ZYPREXA tablet še naslednje pomožne snovi:
English: Discard the syringe and any unused solution in accordance with appropriate clinical procedures.
Slovenian: Zavrzite brizgo in morebitni preostanek raztopine v skladu z ustreznimi kliničnimi postopki.
English: ZYPREXA Injection is given when rapid control of agitation and distressing behaviour is needed and treatment with ZYPREXA tablets is not appropriate.
Slovenian: ZYPREXA injekcijo uporabljamo, ko je potrebna hitra vzpostavitev nadzora agitacije in vedenjskih motenj in ko zdravljenje z ZYPREXA tabletami ni primerno.
English: If you stop taking ZYPREXA
Slovenian: Če ste prenehali jemati zdravilo ZYPREXA
English: Consult your doctor if your symptoms return but do not stop taking ZYPREXA unless your doctor tells you to.
Slovenian: Če se simptomi povrnejo, se posvetujte s svojim zdravnikom, vendar ne prenehajte jemati zdravila ZYPREXA, če vam tega ne naroči vaš zdravnik.
English: After ZYPREXA Injection is made into a solution, use within one hour.
Slovenian: Po pripravi raztopine ZYPREXA injekcije to uporabite v eni uri.
English: • Tell the doctor if you or someone else in your family has a history of blood clots, as medicines like these have been associated with formation of blood clots.
Slovenian: • Če ste vi ali kdo iz vaše družine v preteklosti imeli krvne strdke, morate o tem obvestiti svojega zdravnika, saj lahko zdravila, kot je to, povzročijo nastanek krvnih strdkov.
English: Common ( ≥ 1/100 to < 1/10): Bradycardia with or without hypotension or syncope, tachycardia.
Slovenian: Pogosto (≥ 1/100 do < 1/10): Bradikardija z ali brez hipotenzije ali sinkope, tahikardija.
English: The dose and dose range need not be routinely altered for non-smokers relative to smokers.
Slovenian: Odmerka in razpona odmerkov za nekadilce ni treba rutinsko spreminjati glede na kadilce.
English: ZYPREXA Injection belongs to a group of medicines called antipsychotics and is used to treat symptoms of agitation and distressing behaviour that may occur in the following conditions:
Slovenian: ZYPREXA injekcija spada v skupino zdravil, imenovanih antipsihotiki, in se uporablja za zdravljenje simptomov vznemirjenosti in vedenjskih motenj, ki se lahko pojavijo pri naslednjih boleznih:
English: ZYPREXA tablets contain lactose.
Slovenian: ZYPREXA tablete vsebujejo laktozo.
English: Blood pressure, pulse, respiratory rate and level of consciousness should be observed regularly and remedial treatment provided if required.
Slovenian: Redno spremljamo krvni tlak, srčni utrip, frekvenco dihanja in raven zavesti ter poskrbimo za odpravljanje neželenih učinkov zdravila, če je potrebno.
English: • medicines for Parkinson's disease.
Slovenian: • zdravila za Parkinsonovo bolezen,
English: Simultaneous injection of intramuscular olanzapine and parenteral benzodiazepine is not recommended due to the potential for excessive sedation, cardiorespiratory depression and in very rare cases, death (see sections 4.5 and 6.2).
Slovenian: Sočasno injiciranje intramuskularnega olanzapina in parenteralnega benzodiazepina zaradi možnosti čezmerne sedacije, kardiorespiratorne depresije in, v redkih primerih, smrti, odsvetujemo (glejte poglavji 4.5 in 6.2).
English: The following table is based on the undesirable effects and laboratory investigations from clinical trials with ZYPREXA powder for solution for injection rather than oral olanzapine.
Slovenian: Naslednja tabela temelji na neželenih učinkih in laboratorijskih preiskavah kliničnih preskušanj ZYPREXA praška za raztopino za injiciranje in ne kliničnih preskušanj peroralnega olanzapina.
English: • If you know that you may have salt depletion as a result of prolonged severe diarrhoea and vomiting
Slovenian: • če veste, da imate morda pomanjkanje soli zaradi dolgotrajne hude driske in bruhanja ali uporabe diuretikov (tablet za odvajanje vode)
English: What ZYPREXA is and what it is used for
Slovenian: Kaj je zdravilo ZYPREXA in za kaj ga uporabljamo
English: Additional injections, when indicated, should be conservative in such patients.
Slovenian: Pri dajanju dodatnih injekcij, kadar je to indicirano, je pri teh bolnikih potrebna previdnost.
English: Olanzapine for injection should not be combined in a syringe with haloperidol injection because the resulting low pH has been shown to degrade olanzapine over time.
Slovenian: Olanzapina za injiciranje v brizgi ne smemo mešati s haloperidolom za injiciranje, ker se je za posledično nizko pH vrednost izkazalo, da sčasoma razgradi olanzapin.
English: Patients treated with any antipsychotic medicines, including ZYPREXA, should be monitored regularly for lipids in accordance with utilised antipsychotic guidelines, e.g. at baseline, 12 weeks after starting olanzapine treatment and every 5 years thereafter.
Slovenian: Bolnike, zdravljene s katerimkoli antipsihotikom, vključno z zdravilom ZYPREXA, moramo redno spremljati glede lipidov, v skladu z znanimi priporočili za antipsihotike, npr. na začetku, 12 tednov po začetku jemanja olanzapina in nato vsakih 5 let.
English: Treatment with ZYPREXA powder for solution for injection should be discontinued and the use of oral olanzapine should be initiated as soon as clinically appropriate.
Slovenian: Zdravljenje z ZYPREXA praškom za raztopino za injiciranje je treba prekiniti in začeti uporabljati peroralni olanzapin, kakor hitro je to klinično primerno.
English: Long-term olanzapine treatment (up to 12 months) for recurrence prevention in patients with bipolar disorder was associated with an increase of ≥ 7% from baseline body weight in 39.9% of patients.
Slovenian: Dolgoročno zdravljenje z olanzapinom (do 12 mesecev) za preprečevanje ponovnega pojava bolezni pri bolnikih z bipolarno motnjo je bilo povezano s povečanjem telesne mase za ≥ 7 % z osnove pri 39,9 % bolnikov.
English: Your doctor will decide how much ZYPREXA you need and how long you need it for.
Slovenian: Vaš zdravnik bo odločil, koliko zdravila ZYPREXA potrebujete in za kako dolgo.
English: IM olanzapine has not been studied in patients with alcohol or drug intoxication (see section 4.4).
Slovenian: olanzapina niso preučevali pri bolnikih z intoksikacijo z alkoholom ali drogami (glejte poglavje 4.4).
English: IM olanzapine should not be administered to patients with unstable medical conditions, such as acute myocardial infarction, unstable angina pectoris, severe hypotension and/or bradycardia, sick sinus syndrome, or following heart surgery.
Slovenian: olanzapina ne smemo dajati bolnikom z nestabilnimi zdravstvenimi stanji, kot so npr. akutni miokardni infarkt, nestabilna angina pektoris, huda hipotenzija in/ali bradikardija, sindrom bolezni sinusnega vozla ali po operaciji na srcu.
English: ZYPREXA with alcohol
Slovenian: Jemanje zdravila ZYPREXA skupaj z alkoholom
English: In a pharmacokinetic study in healthy volunteers, a dose of 5 mg of ZYPREXA powder for solution for injection produced a maximum plasma concentration (Cmax) approximately 5 times higher than that seen with the same dose of olanzapine administered orally.
Slovenian: V farmakokinetični študiji pri zdravih prostovoljcih je odmerek 5 mg ZYPREXA praška za raztopino za injiciranje povzročil približno 5-krat višjo maksimalno plazemsko koncentracijo (Cmax), kot jo vidimo pri enakem odmerku olanzapina, danega peroralno.
English: 44 patients with schizophrenia > 65 years of age, dosing from 5 to 20 mg/day was not associated with any distinguishing profile of adverse events.
Slovenian: 44 bolnikih s shizofrenijo, starejših od 65 let, odmerjanje od 5 do 20 mg/dan ni bilo povezano s kakim razločevalnim profilom neželenih učinkov.
English: No other solutions should be used for reconstitution (see section
Slovenian: Za pripravo se ne sme uporabljati drugih raztopin (glejte poglavje 6.2).
English: Type I, 5 ml glass vial.
Slovenian: 5 ml viala iz stekla tipa I.
English: ZYPREXA has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olanzapine treatment.
Slovenian: Zdravilo ZYPREXA dokazano preprečuje ponoven pojav teh simptomov pri bolnikih z bipolarno motnjo, pri katerih se je manična epizoda po zdravljenju z olanzapinom izboljšala.
English: Cold-formed aluminium blister strips in cartons of 28, 35, 56, 70 or 98 tablets per carton.
Slovenian: Hladno-oblikovani aluminijasti pretisni omoti v škatlah po 28, 35, 56, 70 ali 98 tablet.
English: The vial contains 11.0 mg olanzapine as a solution of 5 mg/ml (1 mg olanzapine is retained in the vial and syringe, thus allowing delivery of 10 mg olanzapine).
Slovenian: Viala vsebuje 11,0 mg olanzapina v obliki raztopine 5 mg/ml (1 mg olanzapina ostane v viali in brizgi, kar omogoča injiciranje 10 mg olanzapina).
English: Adults Schizophrenia: The recommended starting dose for olanzapine is 10 mg/day.
Slovenian: Shizofrenija: Priporočeni začetni odmerek olanzapina je 10 mg na dan.
English: ZYPREXA Powder for Solution for Injection must not be combined in the syringe with any commercially available medicinal products because of incompatibilities.
Slovenian: ZYPREXA praška za raztopino za injiciranje v brizgi ne smemo mešati s katerimkoli zdravilom, ki je na trgu, zaradi inkompatibilnosti.
English: Patients treated with any antipsychotic medicines, including ZYPREXA, should be observed for signs and symptoms of hyperglycaemia (such as polydipsia, polyuria, polyphagia, and weakness) and patients with diabetes mellitus or with risk factors for diabetes mellitus should be monitored regularly for worsening of glucose control.
Slovenian: ZYPREXA, moramo opazovati za znake in simptome hiperglikemije (kot so polidipsija, poliurija, polifagija in šibkost) ter redno spremljati bolnike s sladkorno boleznijo ali dejavniki tveganja za sladkorno bolezen glede poslabšanja nadzora glukoze.
English: The dose for patients aged over 65 years is 2.5 mg or 5 mg.
Slovenian: V 24 urah se sme dati do 20 mg. Odmerek za bolnike, starejše od 65 let, je 2,5 mg ali 5 mg.
English: You should swallow the ZYPREXA tablets whole with water.
Slovenian: ZYPREXA tablete pogoltnite cele z vodo.
English: Caution should be exercised in patients who consume alcohol or receive medicinal products that can induce hypotension, bradycardia, respiratory or central nervous system depression (see section 4.4).
Slovenian: Pri bolnikih, ki prejemajo zdravila, ki lahko povzročijo hipotenzijo, bradikardijo, depresijo dihanja ali osrednjega živčevja, je potrebna previdnost (glejte poglavje 4.4).
English: Some people may feel dizzy or faint (with a slow heart rate) after injection, especially when getting up from a lying or sitting position.
Slovenian: Nekateri ljudje imajo lahko po injekciji občutek omotice ali oslabelosti (z upočasnjenim srčnim utripom), zlasti pri vstajanju iz ležečega ali sedečega položaja.
English: • If you have had a recent heart attack, or have heart disease, including sick sinus syndrome,
Slovenian: • Če ste pred kratkim preživeli srčni napad, ali imate srčno obolenje, vključno s sindromom bolezni sinusnega vozla, nestabilno angino pektoris, ali imate nizek krvni tlak.
English: Uncommon side effects (may affect up to 1 in 100 people) include breathing more slowly; and abnormal rhythms of the heart, which can be serious.
Slovenian: Občasni neželeni učinki (lahko prizadenejo do 1 od 100 bolnikov) vključujejo počasnejše dihanje in motnje srčnega ritma, ki so lahko resne.
English: Not more than three injections should be given in any 24 hour period and the maximum daily dose of olanzapine of 20 mg (including all formulations) should not be exceeded.
Slovenian: V obdobju 24 ur ne smemo dati več kot 3 injekcij, pri čemer najvišjega dnevnega odmerka olanzapina, 20 mg (velja za vse oblike), ne smemo preseči.
English: What ZYPREXA Injection looks like and contents of the pack ZYPREXA comes as a yellow powder in a vial.
Slovenian: Izgled ZYPREXA injekcije in vsebina pakiranja Zdravilo ZYPREXA je na voljo kot rumen prašek v viali.
English: 12 Adverse event identified from spontaneous post-marketing reporting with frequency estimated at the upper limit of the 95 % confidence interval utilising the Olanzapine Integrated Database.
Slovenian: 12 Neželeni učinki, ugotovljeni pri spontanem poročanju v obdobju trženja s pogostostjo, ocenjeno na zgornjo mejo 95 % intervala zaupanja, določeno z uporabo integrirane baze podatkov za olanzapin.
English: What ZYPREXA is and what it is used for What you need to know before you are given ZYPREXA How ZYPREXA is given
Slovenian: Kaj je zdravilo ZYPREXA in zakaj ga uporabljamo Kaj morate vedeti, preden boste dobili zdravilo ZYPREXA Kako dobite zdravilo ZYPREXA
English: In post marketing reports, temporal association of treatment with IM olanzapine with cases of respiratory depression, hypotension or bradycardia and death have been very rarely reported, mostly in patients who concomitantly received benzodiazepines, and/or other antipsychotic medicinal products or who were treated in excess of olanzapine recommended daily doses (see sections 4.4 and 4.5).
Slovenian: V poročilih po uvedbi zdravila na trg so zelo redko poročali o časovni povezavi zdravljenja z intramuskularnim olanzapinom s primeri depresije dihanja, hipotenzije ali bradikardije in smrti, zlasti pri bolnikih, ki so sočasno prejemali benzodiazepine in/ali druga antipsihotična zdravila ali so prejemali odmerke olanzapina, višje od priporočenih dnevnih odmerkov (glejte poglavji 4.4 in 4.5).
English: ZYPREXA coated tablets are for oral use.
Slovenian: ZYPREXA obložene tablete so za peroralno uporabo.
English: Your doctor or nurse will make it up into a solution that will be given as an injection.
Slovenian: Vaš zdravnik ali medicinska sestra bo pripravil iz praška raztopino, ki vam jo bodo injicirali.
English: The vial contains 11.0 mg olanzapine as a solution of 5 mg/ml.
Slovenian: Viala vsebuje 11,0 mg olanzapina v obliki raztopine 5 mg/ml.
English: For storage conditions of the reconstituted medicinal product, see section 6.3.
Slovenian: Za pogoje shranjevanja rekonstituiranega zdravila glejte poglavje 6.3. 6.5 Vrsta ovojnine in vsebina
English: If the patient's medical history with regard to these unstable medical conditions cannot be determined, the risks and benefits of IM olanzapine should be considered in relation to other alternative treatments.
Slovenian: Če bolnikovih preteklih bolezni glede na ta nestabilna zdravstvena stanja ni mogoče opredeliti, je treba upoštevati tveganja in koristi i.m.
English: METHOD AND ROUTE(S) OF ADMINISTRATION Intramuscular use.
Slovenian: POSTOPEK IN POT(I) UPORABE ZDRAVILA Za intramuskularno uporabo.
English: ZYPREXA powder for solution for injection is indicated for the rapid control of agitation and disturbed behaviours in patients with schizophrenia or manic episode, when oral therapy is not appropriate.
Slovenian: ZYPREXA prašek za raztopino za injiciranje je indiciran za hitro obvladovanje vznemirjenosti in vedenjskih motenj pri bolnikih s shizofrenijo ali manično epizodo, kadar peroralno zdravljenje ni primerno.
English: Manufacturer Lilly S.A., Avda.
Slovenian: Izdelovalec Lilly S.A., Avda.
English: Olanzapine administered with lithium or valproate resulted in increased levels (≥ 10%) of tremor, dry mouth, increased appetite, and weight gain.
Slovenian: Olanzapin dan z litijem ali valproatom je povzročil zvišane ravni (≥ 10 %) tresenja, suhih ust, povečanega apetita in povečanja telesne mase.
English: The metabolic profiles following intramuscular and oral use are similar.
Slovenian: Podobni so si tudi presnovni profili po intramuskularni in peroralni uporabi.
English: Powder for solution for injection Lilly S.A., Avda.
Slovenian: Prašek za raztopino za injiciranje Lilly S.A., Avda.
English: If you have any further questions on the use of this medicine, ask your doctor or nurse.
Slovenian: Če imate dodatna vprašanja o uporabi tega zdravila, se posvetujte z zdravnikom ali z medicinsko sestro.
English: The major circulating metabolite is the 10-N-glucuronide, which does not pass the blood brain barrier.
Slovenian: V krvi je poglavitni metabolit 10-Nglukuronid, ki ne prehaja skozi krvno-možganskopregrado.
English: Concomitant use of benzodiazepines and other medicinal products Special caution is necessary in patients who have received treatment with other medicinal products having haemodynamic properties similar to those of intramuscular olanzapine including other antipsychotics (oral and/or intramuscular) and benzodiazepines (see section 4.5).
Slovenian: Posebna previdnost je potrebna pri bolnikih, ki so prejeli druga zdravila, ki imajo podobne hemodinamske lastnosti kot intramuskularni olanzapin, vključno z drugimi antipsihotiki (peroralnimi in/ali intramuskularnimi) in benzodiazepini (glejte poglavje 4.5).
English: The undesirable effects listed below have been observed following administration of oral and prolonged release intramuscular injection olanzapine, but may also occur following administration of ZYPREXA powder for solution for injection.
Slovenian: Neželene učinke, naštete spodaj, so opažali po dajanju peroralnega olanzapina in intramuskularne injekcije olanzapina s podaljšanim sproščanjem, lahko pa se pojavijo tudi po dajanju ZYPREXA praška za raztopino za injiciranje.
English: Lorazepam injection should not be used to reconstitute olanzapine for injection as this combination results in a delayed reconstitution time.
Slovenian: Lorazepama za injiciranje ne smemo uporabljati za rekonstitucijo olanzapina za injiciranje, ker taka kombinacija podaljša čas rekonstitucije.
English: There is a risk of feeling drowsy when you are given ZYPREXA.
Slovenian: Obstaja tveganje, da se boste po tem, ko ste dobili zdravilo ZYPREXA, počutili zaspane.
English: Common (≥ 1/100 to < 1/10): Postural hypotension, hypotension.
Slovenian: Pogosto (≥ 1/100 do < 1/10): Posturalna hipotenzija, hipotenzija.
English: Like all medicines, ZYPREXA injection can cause side effects, although not everybody gets them.
Slovenian: Možni neželeni učinki Kot vsa zdravila ima lahko tudi zdravilo ZYPREXA injekcija neželene učinke, ki pa se ne pojavijo pri vseh bolnikih.
English: If this happens after you have been given ZYPREXA tell your doctor.
Slovenian: Če se vam to zgodi po tem, ko ste prejeli zdravilo ZYPREXA, povejte svojemu zdravniku.
English: Adults Olanzapine is indicated for the treatment of schizophrenia.
Slovenian: Olanzapin je indiciran za zdravljenje shizofrenije.
English: Olanzapine for injection may not be combined in a syringe nor should it be used concomitantly with benzodiazepines.
Slovenian: Olanzapina za injiciranje v brizgi ne smemo mešati z benzodiazepini ali ga dajati sočasno z njimi.
English: Uncommon (≥ 1/1,000 to < 1/100): Hypoventilation.
Slovenian: Občasno (≥ 1/1.000 do < 1/100): Hipoventilacija.
English: The following symptoms may occur in newborn babies, of mothers that have used ZYPREXA in the last trimester (last three months of their pregnancy): shaking, muscle stiffness and/or weakness, sleepiness, agitation, breathing problems, and difficulty in feeding.
Slovenian: Pri novorojenčkih mater, ki so v zadnjih treh mesecih nosečnosti uporabljale zdravilo ZYPREXA, se lahko pojavijo naslednji simptomi: tresenje, okornost ali šibkost mišic, zaspanost, nemir, težave z dihanjem in motnje hranjenja.
English: Olanzapine is not indicated for the treatment of children and adolescent patients below 18 years.
Slovenian: Pediatrična populacija Olanzapin ni indiciran za zdravljenje otrok in mladostnikov mlajših od 18 let.
English: < 1.467 mmol/l) to high (≥ 1.467 mmol/l).
Slovenian: (≥ 1,016 mmol/l - < 1,467 mmol/l) na visoke (≥ 1,467 mmol/l).